Bio-Preserve Announces Successful Trade Show Appearance, Lab Space Expansion.REDMOND, Wash.--(BW HealthWire)--May 28, 1998--Bio-Preserve International Corporation (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : BIPN) announced today that its subsidiary, Bio-Preserve Medical Corporation, exhibited the new LifeSustainer(TM) 1000 organ perfusion perfusion /per·fu·sion/ (-zhun) 1. the act of pouring over or through, especially the passage of a fluid through the vessels of a specific organ. 2. a liquid poured over or through an organ or tissue. at the 1998 FASEB FASEB Federation of American Societies for Experimental Biology experimental biology conference in San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden in April. The Company received expressions of interest from numerous potential purchasers, including research scientists and organizations, schools and universities, major pharmaceutical corporations, and teaching hospitals. As a result of the conference, Bio-Preserve Medical has also entered into preliminary discussions with two original equipment manufacturers interested in strategic alliances. The company further announced that it has expanded its laboratory and office space in Redmond by over 300 percent. "I am pleased with the company's recent progress. The successful debut of the LifeSustainer(TM) 1000 at the FASEB conference demonstrates the value of Bio-Preserve's organpreservation technology and paves the way for the introduction of the LifeSustainer(TM) 2000 organ transportation device. We are also seeing an increasing demand for contract drug studies. This was a good time for us to expand our facilities," stated Arthur Karuna-Karan, Ph.D., Chief Executive Officer and a Director of Bio-Preserve International. Bio-Preserve Medical Corporation, a subsidiary of Bio-Preserve International Corporation, is engaged in the research and development of organ preservation device technology based on perfusion, the circulation of fluids in an isolated organ using the organ's own vascular network. The company's products bring together the diverse components used for perfusion into clean, compact, effective, user-friendly devices. Such devices are used in biomedical research Biomedical research (or experimental medicine), in general simply known as medical research, is the basic research or applied research conducted to aid the body of knowledge in the field of medicine. , to preserve human organs for transplants Transplants are an American punk rock/rap rock supergroup. They formed in 1999 when Tim Armstrong of the band Rancid played his friend and roadie Rob Aston some beats he had made using Pro Tools and asked Rob if he would consider contributing lyrics. and for therapeutic treatment of isolated organs. The company also intends to provide organ preservation and perfusion research services to pharmaceutical and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. as well as non-profit research institutions interested in using isolated organs for drug discovery and other types of biomedical research.
CONTACT: For investor information:
Investor Communications Co., 800/457-5580 or 800/457-5579
or
Harvey Wish, 888/852-2212
|
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion